Subscribe To
vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update
HIGH POINT, N.C. , Aug. 11, 2023 (GLOBE NEWSWIRE) ā vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes (āT1Dā), today reported financial results for the second quarter ended June 30, 2023, and provided an [ā¦] The post vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update appeared first on ForexTV...
Read More
Posted: Aug 11 2023, 20:30
Author Name: forextv
Views: 102236